Financials data is unavailable for this security.
View more
Year on year Daiichi Sankyo Co Ltd grew revenues 25.28% from 1.28tn to 1.60tn while net income improved 83.84% from 109.19bn to 200.73bn.
Gross margin | 75.30% |
---|---|
Net profit margin | 13.60% |
Operating margin | 15.44% |
Return on assets | 7.58% |
---|---|
Return on equity | 14.10% |
Return on investment | 9.48% |
More ▼
Cash flow in JPYView more
In 2024, Daiichi Sankyo Co Ltd increased its cash reserves by 46.45%, or 205.26bn. The company earned 590.04bn from its operations for a Cash Flow Margin of 36.84%. In addition the company used 282.64bn on investing activities and also paid 123.56bn in financing cash flows.
Cash flow per share | 1.07 |
---|---|
Price/Cash flow per share | 32.67 |
Book value per share | 6.34 |
---|---|
Tangible book value per share | 5.27 |
More ▼
Balance sheet in JPYView more
Current ratio | 3.11 |
---|---|
Quick ratio | 2.44 |
Total debt/total equity | 0.059 |
---|---|
Total debt/total capital | 0.0558 |
More ▼
Growth rates in JPY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 23.27% and 85.90%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Major Drugs industry pay a dividend.
Div yield(5 year avg) | 0.48% |
---|---|
Div growth rate (5 year) | -- |
Payout ratio (TTM) | 41.85% |
EPS growth(5 years) | -- |
---|---|
EPS (TTM) vs TTM 1 year ago | 55.61 |
More ▼